Annual Total Debt
$4.91 M
-$40.86 M-89.28%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual total debt is currently $4.91 million, with the most recent change of -$40.86 million (-89.28%) on 31 December 2023. During the last 3 years, it has fallen by -$36.09 million (-88.03%). EYPT annual total debt is now -90.21% below its all-time high of $50.12 million, reached on 31 December 2019.EYPT Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$21.92 M
-$1.37 M-5.89%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly total debt is currently $21.92 million, with the most recent change of -$1.37 million (-5.89%) on 30 September 2024. Over the past year, it has increased by +$15.68 million (+251.15%). EYPT quarterly total debt is now -58.84% below its all-time high of $53.26 million, reached on 30 September 2020.EYPT Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -89.3% | +251.2% |
| 3 y3 years | -88.0% | -42.9% |
| 5 y5 years | -72.2% | -56.4% |
EYPT Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -89.3% | at low | -52.8% | +374.1% |
| 5 y | 5 years | -90.2% | at low | -58.8% | +374.1% |
| alltime | all time | -90.2% | -58.8% |
EyePoint Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $21.92 M(-5.9%) |
| June 2024 | - | $23.29 M(+403.8%) |
| Mar 2024 | - | $4.62 M(-5.7%) |
| Dec 2023 | $4.91 M(-89.3%) | $4.91 M(-21.4%) |
| Sept 2023 | - | $6.24 M(-2.8%) |
| June 2023 | - | $6.42 M(-84.1%) |
| Mar 2023 | - | $40.39 M(-11.8%) |
| Dec 2022 | $45.77 M(+16.7%) | $45.77 M(-1.5%) |
| Sept 2022 | - | $46.46 M(+4.4%) |
| June 2022 | - | $44.48 M(+7.8%) |
| Mar 2022 | - | $41.28 M(+5.3%) |
| Dec 2021 | $39.20 M(-4.4%) | $39.20 M(+2.1%) |
| Sept 2021 | - | $38.41 M(+0.4%) |
| June 2021 | - | $38.25 M(-5.1%) |
| Mar 2021 | - | $40.30 M(-1.7%) |
| Dec 2020 | $40.99 M(-18.2%) | $40.99 M(-23.0%) |
| Sept 2020 | - | $53.26 M(+0.7%) |
| June 2020 | - | $52.88 M(+4.8%) |
| Mar 2020 | - | $50.48 M(+0.7%) |
| Dec 2019 | $50.12 M(+184.4%) | $50.12 M(-0.2%) |
| Sept 2019 | - | $50.22 M(+0.8%) |
| June 2019 | - | $49.84 M(+39.9%) |
| Mar 2019 | - | $35.63 M(+104.1%) |
| Dec 2018 | $17.62 M(+1.8%) | - |
| Sept 2018 | - | $17.46 M(+0.9%) |
| June 2018 | $17.31 M(>+9900.0%) | $17.31 M(+34.7%) |
| Mar 2018 | - | $12.85 M(>+9900.0%) |
| Dec 2017 | - | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | - | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | - | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | - | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | - | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | - | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | - | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | - | $0.00(0.0%) |
| Sept 2008 | - | $0.00(0.0%) |
| June 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | - | $0.00(0.0%) |
| Sept 2007 | - | $0.00(0.0%) |
| June 2007 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2007 | - | $0.00(-100.0%) |
| Dec 2006 | - | $9.07 M(>+9900.0%) |
| Sept 2006 | - | $0.00(-100.0%) |
| June 2006 | $11.26 M(>+9900.0%) | $11.26 M(>+9900.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | - | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | - | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | - | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | - | $0.00(0.0%) |
| Sept 2002 | - | $0.00 |
| June 2002 | $0.00(-100.0%) | - |
| June 2001 | $145.70 K | - |
FAQ
- What is EyePoint Pharmaceuticals annual total debt?
- What is the all time high annual total debt for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual total debt year-on-year change?
- What is EyePoint Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly total debt year-on-year change?
What is EyePoint Pharmaceuticals annual total debt?
The current annual total debt of EYPT is $4.91 M
What is the all time high annual total debt for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual total debt is $50.12 M
What is EyePoint Pharmaceuticals annual total debt year-on-year change?
Over the past year, EYPT annual total debt has changed by -$40.86 M (-89.28%)
What is EyePoint Pharmaceuticals quarterly total debt?
The current quarterly total debt of EYPT is $21.92 M
What is the all time high quarterly total debt for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly total debt is $53.26 M
What is EyePoint Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, EYPT quarterly total debt has changed by +$15.68 M (+251.15%)